CERo Therapeutics Holdings Inc (CERO) concluded trading on Thursday at a closing price of $0.96, with 5.96 million shares of worth about $5.72 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -89.74% during that period and on March 13, 2025 the price saw a loss of about -29.40%. Currently the company’s common shares owned by public are about 3.03M shares, out of which, 2.37M shares are available for trading.
Stock saw a price change of -34.23% in past 5 days and over the past one month there was a price change of -48.10%. Year-to-date (YTD), CERO shares are showing a performance of -84.00% which decreased to -99.67% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.26 but also hit the highest price of $376.00 during that period. The average intraday trading volume for CERo Therapeutics Holdings Inc shares is 666.55K. The stock is currently trading -39.60% below its 20-day simple moving average (SMA20), while that difference is down -60.14% for SMA50 and it goes to -94.19% lower than SMA200.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) currently have 3.03M outstanding shares and institutions hold larger chunk of about 1.30% of that.
The stock has a current market capitalization of $2.91M and its 3Y-monthly beta is at 0.47. It has posted earnings per share of -$43.79 in the same period. It has Quick Ratio of 0.39. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CERO, volatility over the week remained 15.30% while standing at 12.98% over the month.
